E2 ModerateModerate confidencePEM not requiredObservationalPeer-reviewedReviewed
Standard · 3 min
Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway.
Naess, Halvor, Sundal, Endre, Myhr, Kjell-Morten et al. · In vivo (Athens, Greece) · 2010
Quick Summary
This study looked at 873 ME/CFS patients in Norway to see whether their illness started after an infection. About 77% of patients reported having an infection before their fatigue began. Patients who had an infection at the start were more likely to have a sudden onset of fatigue and to show some improvement by the time they were seen at the clinic, compared to those without an infection.
Why It Matters
Understanding whether ME/CFS symptoms differ based on initial infectious trigger may help identify disease subtypes and guide clinical management. This study provides data on the frequency and characteristics of postinfectious presentations in a substantial tertiary cohort, supporting the recognition that infection-triggered ME/CFS may represent a distinct phenotype with potentially better prognosis.
Observed Findings
77% of ME/CFS patients reported an acute infection preceding symptom onset
Patients with initial infection reported more acute onset of fatigue compared to those without
No significant differences in EBV or enterovirus antibody presence between infection and non-infection groups
Fever, tender lymph nodes, and myalgia were more frequently reported at referral in patients with initial infection
Patients with initial infection showed more frequent improvement of fatigue by the time of clinic referral
Inferred Conclusions
Initial infection is an important precipitating factor in the majority of ME/CFS cases and is independently associated with acute symptom onset and a more pronounced inflammatory symptom profile
Postinfectious ME/CFS may represent a distinct clinical phenotype with potentially better prognosis, characterized by more acute onset and higher likelihood of improvement
Standard antibody testing against common viral agents may not distinguish between patients with and without infectious triggers
Remaining Questions
What mechanisms explain why infection-triggered ME/CFS is associated with better improvement rates?
What determines whether individuals develop postinfectious ME/CFS versus full recovery after acute infection?
What This Study Does Not Prove
This study does not establish that infection causes ME/CFS—only that infection preceding symptom onset is common and associated with certain symptom patterns. The lack of antibody differences between groups does not rule out infectious etiology and may reflect limitations in serological detection. The observational design cannot determine causality or why some patients improve while others do not.
Tags
Symptom:PainFatigueTemperature Dysregulation
Biomarker:Autoantibodies
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
Why were no serological differences found between groups, and what unmeasured infectious agents or immune mechanisms might explain postinfectious presentations?
Do patients without reported infection have a genuinely different disease mechanism, or does recall bias affect this distinction?